Group One Trading
AURA icon

Group One Trading’s Aura Biosciences AURA Stock Holding History

Group One Trading’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-189
Closed -$1.68K – 7244
2024
Q3 		$1.68K Buy
+189
New +$1.62K ﹤0.01% 6188

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Group One Trading's AURA Position: Q4 2024 in Review

Group One Trading sold out of Aura Biosciences (AURA) in Q4 2024, closing a stake of 189 shares — an estimated $1.68K sold.

Group One Trading first reported a position in AURA in Q3 2024 and held it in 1 quarter. The position peaked at $1.68K in Q3 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q4 2024.

  • Group One Trading reported no remaining Aura Biosciences position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 189 Aura Biosciences shares in Q4 2024, an estimated $1.68K.
  • Group One Trading first reported a position in Aura Biosciences in Q3 2024 and held it in 1 quarter.
  • Group One Trading's Aura Biosciences position peaked at $1.68K in Q3 2024.
  • 94 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.